Alpine Associates Management’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Alpine Associates Management’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,451,941	Closed	-$27.1M	–	58
2022 Q1	$27.1M	Buy	1,451,941 +719,141	+98%	+$12.9M	1.16%	30
2021 Q4	$15.7M	Buy	+732,800	New	+$14.4M	0.59%	33

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Alpine Associates Management's OCDX Position: Q2 2022 in Review

Alpine Associates Management sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 1,451,941 shares — an estimated $27.1M sold.

Alpine Associates Management first reported a position in OCDX in Q4 2021 and held it in 2 quarters. The position peaked at $27.1M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Alpine Associates Management reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Alpine Associates Management sold 1,451,941 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $27.1M.
Alpine Associates Management first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q4 2021 and held it in 2 quarters.
Alpine Associates Management's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $27.1M in Q1 2022.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Alpine Associates Management's 13F filing for Q2 2022, filed 9 Aug 2022.